NCT02646540 - AiDing Diuresis wIth Tolvaptan (ADD-IT) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 30, 2018

Study Completion Date

December 30, 2018

Conditions

CardiomyopathyCongestive Heart Failure

Interventions

DRUG

Tolvaptan 30 mg + IV Diuretics

Participants will receive oral daily tolvaptan 30 mg concomitantly with their standard dose of intravenous (IV) diuretics for the duration of their hospitalization.

DRUG

Metolazone 5 mg + IV Diuretics

Participants will receive oral daily metolazone 5 mg concomitantly with their standard dose of intravenous (IV) diuretics for the duration of their hospitalization.

DRUG

2.5 times the Diuretics Dose

Participants will receive two and a half (2.5) times their standard dose of intravenous (IV) diuretics for the duration of their hospitalization.

Trial Locations (2)

30308

Emory University Hospital Midtown, Atlanta

30322

Emory University Hospital, Atlanta

All Listed Sponsors

lead

Emory University

OTHER